DE602004011790D1 - Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung - Google Patents

Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung

Info

Publication number
DE602004011790D1
DE602004011790D1 DE602004011790T DE602004011790T DE602004011790D1 DE 602004011790 D1 DE602004011790 D1 DE 602004011790D1 DE 602004011790 T DE602004011790 T DE 602004011790T DE 602004011790 T DE602004011790 T DE 602004011790T DE 602004011790 D1 DE602004011790 D1 DE 602004011790D1
Authority
DE
Germany
Prior art keywords
salts
sup
acid
meldonium
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004011790T
Other languages
English (en)
Other versions
DE602004011790T2 (de
Inventor
Ivars Kalvinsh
Anatolijs Birmans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Grindeks JSC
Original Assignee
Grindeks JSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LV030087A external-priority patent/LV13279B/lv
Priority claimed from LV030088A external-priority patent/LV13280B/lv
Application filed by Grindeks JSC filed Critical Grindeks JSC
Publication of DE602004011790D1 publication Critical patent/DE602004011790D1/de
Application granted granted Critical
Publication of DE602004011790T2 publication Critical patent/DE602004011790T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/12Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10Hydrazines
    • C07C243/12Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/14Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/16Halogenated acetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/06Oxalic acid
    • C07C55/07Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/10Succinic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02Dicarboxylic acids
    • C07C55/14Adipic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/15Fumaric acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/245Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265Citric acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602004011790T 2003-08-04 2004-07-15 Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung Expired - Lifetime DE602004011790T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
LV030087A LV13279B (en) 2003-08-04 2003-08-04 Non-hygroscopic salts of 3-(2,2,2-trimethylhydrazinum)propionate,a method of production and pharmaceutical compositions thereof
LV030087 2003-08-04
LV030088A LV13280B (en) 2003-08-04 2003-08-04 Sustained release salts of 3-(2,2,2-trimethylhydrazinium)propionate, a method of production and pharmaceutical compositions thereof
LV030088 2003-08-04
PCT/LV2004/000005 WO2005012233A1 (en) 2003-08-04 2004-07-15 Meldonium salts, method of their preparation and pharmaceutical composition on their basis

Publications (2)

Publication Number Publication Date
DE602004011790D1 true DE602004011790D1 (de) 2008-03-27
DE602004011790T2 DE602004011790T2 (de) 2009-03-05

Family

ID=34118016

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004011790T Expired - Lifetime DE602004011790T2 (de) 2003-08-04 2004-07-15 Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung

Country Status (23)

Country Link
US (1) US7223797B2 (de)
EP (1) EP1667960B1 (de)
JP (1) JP4634380B2 (de)
KR (1) KR100745160B1 (de)
AT (1) ATE386014T1 (de)
AU (1) AU2004260779B2 (de)
CA (1) CA2535150C (de)
DE (1) DE602004011790T2 (de)
DK (1) DK1667960T3 (de)
EA (1) EA009083B1 (de)
ES (1) ES2302011T3 (de)
HK (1) HK1093197A1 (de)
HR (1) HRP20080192T3 (de)
IL (1) IL173126A (de)
MA (1) MA28025A1 (de)
MX (1) MXPA06000955A (de)
NO (1) NO334623B1 (de)
NZ (1) NZ545440A (de)
PL (1) PL1667960T3 (de)
PT (1) PT1667960E (de)
SI (1) SI1667960T1 (de)
UA (1) UA82540C2 (de)
WO (1) WO2005012233A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LV13450B (en) * 2004-08-24 2006-11-20 Grindeks As Novel medicinal use of meldonium and pharmaceutical compositions thereof
US10183001B1 (en) * 2007-05-22 2019-01-22 Pisgah Laboratories, Inc. Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
TW200930356A (en) * 2007-12-04 2009-07-16 Grindeks Jsc New medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts
TWI391131B (zh) * 2007-12-05 2013-04-01 Grindeks Jsc 3-(2,2,2-三甲基肼)丙酸鹽的新用途
ES2364017T3 (es) 2007-12-05 2011-08-23 Grindeks, A Joint Stock Company Sales de propionato de 3-(2,2,2-trimethylhydrazinium) para el tratamiento del infarto de miocardio.
EP2067474A1 (de) 2007-12-05 2009-06-10 Grindeks, a joint stock company Neue medizinische Verwendung von 3-(2,2,2-Trimethylhydrazinium)propionat-Salz
WO2009074498A1 (en) * 2007-12-12 2009-06-18 Grindeks Medical use of 3- (2, 2, 2-trimethylhydrazinixm) propionate orotate
WO2009095445A1 (en) * 2008-01-29 2009-08-06 Grindeks New second medical use of 3-(2,2,2-trimethylhydrazine)propionate dihydrate
GEP20125680B (en) * 2008-02-19 2012-10-25 Grindex Publiska As Carbonic and sulphuric acid salts of 3-(2,2,2-trimethylhydra-zinium) ropionate esters and their use for 3-(2,2,2-rimethyl- hydrazinium) propionate dihydrate preparation
EA016876B1 (ru) * 2008-05-26 2012-08-30 Гриндекс, Джоинт Сток Кампани Способ получения дигидрата 3-(2,2,2-триметилгидразиниум) пропионата
EP2128126A1 (de) * 2008-05-26 2009-12-02 Grindeks, a joint stock company Neues Verfahren zur Herstellung von 3-(2,2,2-Trimethylhydrazinium) Propionat-Dihydrat
GEP20135819B (en) * 2008-10-29 2013-05-10 Grindeks Jsc 3-(2,2,2-trimethylhydrazinium) propionate dihydrate composition of local administration
LV14230B (lv) * 2009-04-30 2011-05-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija Parkinsona slimības profilaksei un ārstēšanai
WO2010149654A1 (en) * 2009-06-25 2010-12-29 Grindeks, A Joint Stock Company Pharmaceutical composition of gamma-butyrobetaine or a pharmaceutically acceptable salt and meldonium or a pharmaceutically acceptable salt
BRPI1009600A2 (de) * 2009-06-25 2016-03-22 Tetra S A
LV14268B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldonija sukcinātu saturoši medicīniskie produkti
LV14274B (lv) * 2009-06-25 2011-03-20 Grindeks, A/S Meldoniju saturošs kombinēts medicīniskais produkts
EP2399904A1 (de) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Verfahren zur Herstellung von Pleuromutilinen
EP2420224A1 (de) * 2010-08-11 2012-02-22 Grindeks, a joint stock company Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung aus stabilem 3-(2,2,2-trimethylhydrazinium)propionatdihydrat
PE20140777A1 (es) * 2011-04-27 2014-07-20 Grindeks Jsc Metodo de obtencion de una composicion farmaceutica de sales de 3-carboxi-n-etil-n,n-dimetilpropan-1-aminio para el tratamiento de enfermedades cardiovasculares
RU2458690C1 (ru) * 2011-05-31 2012-08-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее противоишемической активностью
RU2457198C1 (ru) * 2011-05-31 2012-07-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее противоишемической активностью
RU2467745C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-бромникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2467744C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний) пропионата - 5-гидрокисиникотинат 3-(2,2,2-триметилгидразиний) пропионат калия, обладающее эндотелиопротекторной активностью
RU2485953C1 (ru) * 2012-04-12 2013-06-27 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Комплекс 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцинат, обладающий антигипоксическим и адаптогенным действием, и способ его получения
LV14848B (lv) * 2012-10-25 2015-06-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija trimetilamīna-N-oksīda līmeņa pazemināšanai
RU2527347C1 (ru) * 2013-03-12 2014-08-27 Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита" Стабильная жидкая фармацевтическая композиция комплекса 3-(2,2,2-триметилгидразиний) пропионат-2-этил-6-метил-3-гидроксипиридина дисукцината, обладающая антигипоксическим, антиоксидантным и адаптогенным действием
EP2842557A1 (de) * 2013-08-30 2015-03-04 SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Mildronat bei Augenerkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
SU978808A1 (ru) * 1980-01-18 1982-12-07 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Способ регулировани роста растений люпина
SU1680693A1 (ru) * 1987-03-25 1991-09-30 Институт Органического Синтеза Ан Латвсср Этил-3-(2,2-диметил-2-этилгидразиний)пропионат иодистый, про вл ющий антиаритмическую активность
EP0307977B1 (de) * 1987-09-07 1992-09-30 Teikoku Tsushin Kogyo Co. Ltd. Gehäuse aus vergossenem Kunststoff für einen elektronischen Teil mit flachem Kabel
LV11727B (en) * 1995-08-21 1997-08-20 Kalvins Ivars Pharmaceutical composition

Also Published As

Publication number Publication date
WO2005012233A1 (en) 2005-02-10
NO334623B1 (no) 2014-04-28
EA009083B1 (ru) 2007-10-26
KR100745160B1 (ko) 2007-08-01
CA2535150A1 (en) 2005-02-10
UA82540C2 (uk) 2008-04-25
JP4634380B2 (ja) 2011-02-16
EP1667960B1 (de) 2008-02-13
NO20055867L (no) 2006-02-27
EP1667960A1 (de) 2006-06-14
PT1667960E (pt) 2008-05-02
MXPA06000955A (es) 2006-03-30
MA28025A1 (fr) 2006-07-03
AU2004260779B2 (en) 2009-01-22
IL173126A (en) 2011-02-28
ATE386014T1 (de) 2008-03-15
US7223797B2 (en) 2007-05-29
DE602004011790T2 (de) 2009-03-05
ES2302011T3 (es) 2008-07-01
SI1667960T1 (sl) 2008-08-31
US20060264506A1 (en) 2006-11-23
AU2004260779A1 (en) 2005-02-10
PL1667960T3 (pl) 2008-06-30
KR20060059995A (ko) 2006-06-02
DK1667960T3 (da) 2008-06-09
NZ545440A (en) 2009-03-31
JP2007501222A (ja) 2007-01-25
EA200600175A1 (ru) 2006-08-25
WO2005012233A8 (en) 2005-05-19
HRP20080192T3 (en) 2008-05-31
CA2535150C (en) 2010-04-13
HK1093197A1 (en) 2007-02-23
IL173126A0 (en) 2006-06-11

Similar Documents

Publication Publication Date Title
DE602004011790D1 (de) Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung
RU2196769C2 (ru) Производные аминобензойной кислоты, фармацевтическая композиция
ATE31411T1 (de) Piperazin-derivate, verfahren zu ihrer herstellung und diese als aktive bestandteile enthaltende pharmazeutische zusammensetzungen.
HUP0102602A2 (hu) Diacil-hidrazinszármazékok, előállításuk és alkalmazásuk, valamint e vegyületeket tartalmazó gyógyászati készítmények
DE59509647D1 (de) Aminosäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
RU2005109560A (ru) Фармацевтическая композиция, включающая кристаллический полугидрат метансульфоната сибутрамина
HUP9903632A2 (hu) Neuraminsav vegyületek, azokat tartalmazó gyógyszerkészítmények és eljárás e készítmények előállítására
JPH08510477A (ja) 新規なn−ベンゾイルメチル−ピペリジン類
HK1075656A1 (en) New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
RU2342363C2 (ru) Бензоилпиперидиновые соединения
JP5107497B2 (ja) 鎮咳活性を有する1,3−ジオキソラン
JPH09502200A (ja) インドリジン誘導体の製造法
DE60227506D1 (de) DIHYDROIMIDAZOi5,1-A -BETA-CARBOLIN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE ANWENDUNG ALS ARZNEIMITTEL
HU196159B (en) Process for producing aphidicolin derivatives and pharmaceutics comprising the same as active ingredient
KR20210125298A (ko) 테노포비어 알라펜아미드 헤미타르트레이트의 신규한 제조방법
JPH05271220A (ja) アミン誘導体およびこれを含有する降圧剤
GB0114699D0 (en) Organic compounds
JP2001039957A (ja) 新規ベンゾオキサゾール誘導体
JPS59190982A (ja) 4’−フルオロメチル−3−アミノ−2−メチル置換プロピオフエノン誘導体
NO20022891L (no) Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem
HU229801B1 (en) 2,2-disubstituted 1,3-dioxolanes as antitussive agents
TH88189B (th) สารก่อนเป็นยา (prodrug) ที่มีฐานเป็นฟอสฟอนิก แอซิดชนิดใหม่ของ ของ 9-(2-ฟอสฟอนิลเอธอกซิเอธิล)แอเดนีน(PMEA)และแอนะล็อก(analogues) ของมัน
JPS59190980A (ja) 2’−クロロ−3−アミノ−2−メチル置換プロピオフエノン誘導体

Legal Events

Date Code Title Description
8364 No opposition during term of opposition